You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

hmpl-523

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Imumune Thrombocytopenia(ITP) Human Mass Balance Trial in Suzhou (HMPL-523, 150 µCi [14C]HMPL-523)

Recruiting
  • Imumune Thrombocytopenia(ITP) Human Mass Balance
  • HMPL-523
  • 150 µCi [14C]HMPL-523
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Mar 12, 2023

Relapsed or Refractory Lymphoma Trial in Austin (HMPL-523, Itraconazole, Rifampin)

Active, not recruiting
  • Relapsed or Refractory Lymphoma
  • HMPL-523
  • +2 more
  • Austin, Texas
    PPD Austin
Jan 31, 2023

Relapsed or Refractory Lymphoma Trial in Austin (HMPL-523, Rabeprazole)

Completed
  • Relapsed or Refractory Lymphoma
  • Austin, Texas
    PPD Austin
Oct 5, 2022

Healthy Subject Trial (HMPL-523)

Not yet recruiting
  • Healthy Subject
  • HMPL-523
  • (no location specified)
Apr 1, 2022

Non Hodgkin Lymphoma Trial in Worldwide (HMPL-523)

Recruiting
  • Non Hodgkin Lymphoma
  • HMPL-523
  • Anaheim, California
  • +20 more
Oct 4, 2022

Immune Thrombocytopenia (ITP) Trial (HMPL-523, Placebo)

Not yet recruiting
  • Immune Thrombocytopenia (ITP)
  • HMPL-523
  • Placebo
  • (no location specified)
Aug 25, 2021

Immune Thrombocytopenia (ITP) Trial in Tianjin (HMPL-523, Placebo)

Unknown status
  • Immune Thrombocytopenia (ITP)
  • HMPL-523
  • Placebo
  • Tianjin, Tianjin, China
    Blood diseases hospital, Chinese academy of medical university
Oct 20, 2020

Hematologic Malignancies Trial in Australia (HMPL-523)

Unknown status
  • Hematologic Malignancies
  • HMPL-523
  • Canberra, Australian Capital Territory, Australia
  • +11 more
Sep 10, 2020

Mature B-cell Tumors Trial in Beijing, Shanghai (HMPL-523)

Unknown status
  • Mature B-cell Neoplasms
  • HMPL-523
  • Beijing, Beijing, China
  • +1 more
Feb 25, 2020

Acute Myeloid Leukemia Trial in Tianjin (HMPL-523, Azacitidine)

Terminated
  • Acute Myeloid Leukemia
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital, Chinese Acade
Nov 18, 2019

Rheumatoid Arthritis (RA) Trial in Melbourne (HMPL-523, Placebo)

Completed
  • Rheumatoid Arthritis (RA)
  • HMPL-523
  • Placebo
  • Melbourne, Victoria, Australia
    Nucleus Network Limited
Apr 26, 2016